Skip to main content
Chemplast Sanmar Limited logo

Chemplast Sanmar Limited — Investor Relations & Filings

Ticker · CHEMPLASTS ISIN · INE488A01050 LEI · 3358004JVEJ5LMVAP885 BSE.NS Manufacturing
Open in API
Filings indexed 356 across all filing types
Latest filing 2026-05-25 Investor Presentation
Country IN India
Listing BSE.NS CHEMPLASTS

About Chemplast Sanmar Limited

https://www.chemplastsanmar.com/

Chemplast Sanmar Limited is a major manufacturer of specialty chemicals and PVC resins, operating integrated production facilities. The company is a leading producer of Specialty Paste PVC and also manufactures Suspension PVC, Caustic Soda, Chloromethanes, Hydrogen Peroxide, and Refrigerant Gases. Through its Custom Manufactured Chemicals division, it provides contract research and manufacturing services for the agrochemical, pharmaceutical, and fine chemicals sectors. Its products serve a wide range of applications, including leather cloth, flooring, medical gloves, and water treatment. Chemplast Sanmar utilizes vertically integrated processes and technical expertise to supply high-quality chemical intermediates and specialty products to a global customer base, focusing on operational efficiency and product diversification.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled “Investor Presentation – Q4 & FY ’26” and begins with an exchange filing stating “Subject: Investor Presentation – Q4 & FY ’26.” It contains slide content such as Safe Harbour, Performance Highlights, MD’s Message, segmental results, and full financial statements presented in a slide format. This clearly matches the definition of an Investor Presentation (IP).
2026-05-25 English
Investor Presentation - Q4 & FY''26 is attached
Investor Presentation Classification · 95% confidence The document is titled “Investor Presentation – Q4 & FY ’26” and is addressed to stock exchanges with a note that the Investor Presentation for Q4 & FY ’26 is enclosed and available on the company website. The content is a slide‐style presentation (Safe Harbour, Performance Highlights, Segmental Highlights, MD’s Message, consolidated financial statements, etc.), which matches the definition of an Investor Presentation. Therefore, it should be classified as IP.
2026-05-25 English
Change in Director(s)
Audit Report / Information Classification · 84% confidence The document is a formal filing under SEBI LODR Regulation 30 conveying the board’s approval of audited financial results and contains the full Independent Auditor’s Report on those standalone annual financial results for the year ended 31 March 2026. It is not the complete Annual Report (10-K), nor merely a brief announcement, but the actual auditor’s report itself. Hence, it best fits the Audit Report / Information category (AR).
2026-05-25 English
General Updates
Regulatory Filings Classification · 85% confidence The document is a Board Meeting outcome intimation sent to stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30. It includes the approval of audited financial results, auditor’s report, director appointment details, AGM date, and committee constitution. This is not the full annual report or interim report itself but a regulatory announcement/disclosure. It does not primarily present detailed financial statements within the text but notifies that audited results and reports are enclosed. This is a general compliance notification falling under Regulatory Filings (RNS).
2026-05-25 English
Outcome of Board Meeting
Board/Management Information Classification · 85% confidence The document is an exchange filing titled “Outcome of Board Meeting – Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,” detailing board decisions: approval of audited financial results, dividend declaration (nil), AGM date, and most notably the appointment of a new non-executive director. This is a classic Board/Management Information announcement concerning changes in the company’s board composition per regulatory requirements. It is not a standalone annual report (10-K), earnings release, or proxy statement, nor is it merely a notification of report publication. It primarily conveys board/management decisions and director appointments, matching the MANG category.
2026-05-25 English
General Updates
Regulatory Filings Classification · 80% confidence The document is a formal submission under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 detailing the outcome of a board meeting: approval of audited standalone and consolidated results, auditor’s report, dividend decision, AGM date, director appointment, and committee formation. It is not the full Annual Report (10-K) nor a standalone audit report (AR) exclusively; rather it is a routine regulatory disclosure to stock exchanges encompassing results and compliance events. Thus it best fits the ‘General regulatory announcements’ category (RNS).
2026-05-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.